The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?

BACKGROUND & OBJECTIVES: Percutaneous nephrostomy (PN) for malignant ureteric obstruction (MUO) is increasingly accessible with high success rates. However, it is not without associated risks and morbidity, impacting quality of life, while not improving overall survival. In two UK hospitals, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Osinibi, Elizabeth, Doan, Hong, Mercado-Campero, Alejandro, Abbaraju, Jayasimha, Masood, Shikohe, Madaan, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612453/
https://www.ncbi.nlm.nih.gov/pubmed/37901283
http://dx.doi.org/10.1177/17562872231207729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612453/
https://www.ncbi.nlm.nih.gov/pubmed/37901283
http://dx.doi.org/10.1177/17562872231207729

Ejemplares similares